Dr. Jonathan Milner, Deputy Chairman, Abcam plc
- Mon 22nd Jan 2018
- The Wolfson Hall, Churchill College, Storey's Way, Cambridge, CB3 0DS
Lecture details to follow
Background: Having worked in the life sciences industry for over ten years as an academic researcher, Jonathan identified the market opportunity for supplying high quality antibodies to support protein interaction studies and, in 1998, founded Abcam with Dr David Cleevely and Professor Tony Kouzarides.
Current external appointments: Jonathan is a Non-Executive Director of Horizon Discovery Group plc, The Evolution Education Trust, Repositive Ltd, Syndicate Room Group Ltd and HealX. He is also Chairman of Axol Bioscience Ltd, PhoreMost Ltd, Definigen Limited and CamAllergy Ltd. Jonathan holds an Executive Director position at Meltwind Limited, being a designated member of Meltwind Advisory LLP, and is a member of the Advisory Panel of Cambridge Innovation Capital plc.
Skills and experience: Jonathan is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 40 companies and has assisted three AIM IPOs.
The lecture will be preceded by a short presentation from a CSAR PhD Student Award winner
Sarah Madden - Stabilising Omomyc - a new cancer drug